CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Cell Biotech Co ., Limited. Company Snapshot
Cell Biotech Co ., Limited. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cell Biotech Co ., Limited. with three other companies in this sector in South Korea: G-treeBNT Co Ltd (2018 sales of 46.36 billion Korean Won [US$38.11 million] of which 61% was Medicine), Choong Ang Vaccine Laboratory (33.15 billion Korean Won [US$27.25 million] of which 100% was Animal Health Product), and Komipharm International Company Limited (34.99 billion Korean Won [US$28.77 million] of which 96% was Finished Goods).

Sales Analysis. Cell Biotech Co ., Limited. reported sales of 62.54 billion Korean Won (US$51.41 million) for the year ending December of 2018. This represents an increase of 2.4% versus 2017, when the company's sales were 61.06 billion Korean Won. Sales at Cell Biotech Co ., Limited. have increased during each of the previous five years (and since 2013, sales have increased a total of 98%). Sales of Finished Products saw an increase of 2.8% in 2018, from 53.97 billion Korean Won to 55.51 billion Korean Won. Not all segments of Cell Biotech Co ., Limited. experienced an increase in sales in 2018: sales of Raw Material fell 0.7% to 7.03 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Cell Biotech Co ., Limited.
  Stock Performance Chart for Cell Biotech Co ., Limited.
 
  Stock Data: Recent Stock Performance:
  Current Price (8/16/2019): 17,250
(Figures in Korean Won)
1 Week 3.3%   13 Weeks -5.0%  
4 Weeks -20.9%   52 Weeks -48.1%  
 
Cell Biotech Co ., Limited. Key Data:
  Ticker: 049960 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 62,543,665,262
(Year Ending Jan 2019).
Employees: 115
  Currency: Korean Won Market Cap: 129,444,000,000
  Fiscal Yr Ends: December Shares Outstanding: 7,504,000
  Share Type: Common Closely Held Shares: 2,357,573
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.